| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.0055 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |